seizure - Nursing Case Study
Pathophysiology
• Primary mechanism: Seizures result from abnormal electrical discharges in the brain due to imbalances between excitatory and inhibitory neurotransmitters, particularly glutamate and GABA. This imbalance leads to excessive neuronal firing.
• Secondary mechanism: Altered ion channel function, especially sodium and calcium channels, further contributes to hyperexcitability by disrupting normal neuronal depolarization and repolarization processes.
• Key complication: Prolonged seizures can lead to neuronal injury and changes in brain networks, potentially causing cognitive decline and increasing the risk of subsequent seizures, known as epilepsy.
Patient Profile
Demographics:
32-year-old female, graphic designer
History:
• Key past medical history: Diagnosed with epilepsy 5 years ago, hypertension
• Current medications: Lamotrigine, Lisinopril
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increased frequency of seizures over the past month
• Key symptoms: Aura before seizures, confusion postictally, recent episodes of dizziness, occasional headaches
• Vital signs: Blood pressure 150/95 mmHg, heart rate 110 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F
Section 1
During the initial assessment, the healthcare team noted that the patient's neurological status was altered, with a Glasgow Coma Scale score of 13, indicating mild confusion and disorientation. Neurological exam revealed brisk deep tendon reflexes and slight ataxia. The patient's blood pressure remained elevated at 152/98 mmHg, heart rate was steady at 108 bpm, and her oxygen saturation was 96% on room air. Laboratory results showed a slight hyponatremia with a serum sodium level of 132 mmol/L, which can exacerbate seizure activity by altering neuronal excitability. Lamotrigine plasma levels were noted to be at the lower end of the therapeutic range, suggesting possible subtherapeutic dosing contributing to the increased seizure frequency.
In response to these findings, the clinical team decided to adjust the patient's lamotrigine dose, considering her clinical presentation and recent seizure activity. Additionally, they initiated a workup to explore potential secondary causes for the increased seizure frequency, including an MRI of the brain to rule out structural changes or lesions and an EEG to assess for any changes in seizure patterns or new epileptiform discharges. The team also planned to manage her hypertension more aggressively, given its role as a potential trigger for seizures, by discussing lifestyle modifications and considering an adjustment in her antihypertensive regimen.
As the patient's condition continued to be monitored, she experienced a new complication: a focal seizure that lasted longer than previous episodes, characterized by right-sided facial twitching and difficulty speaking, with postictal weakness on the same side. This new development raised concerns about the potential evolution of her seizure disorder and the risk of focal-to-bilateral tonic-clonic seizures if not adequately managed. The team recognized the need for urgent intervention to prevent further complications and to stabilize her condition, emphasizing the importance of comprehensive and dynamic management of her epilepsy and associated hypertension.
Section 2
The team decided to conduct an urgent reassessment following the focal seizure, focusing on any new diagnostic results that could inform their management plan. The MRI of the brain returned with findings of a small cortical lesion in the left frontal lobe, which was not prominent enough to suggest a clear etiology but potentially contributory to her focal seizure activity. The EEG showed intermittent left frontal slowing and rare epileptiform discharges, correlating with the region of the cortical lesion. This prompted a discussion about the potential for a structural etiology underlying her seizures, and the need for a possible neurology consult to explore further diagnostic or therapeutic interventions.
Meanwhile, the patient's blood pressure continued to be a concern, with readings averaging around 158/100 mmHg despite initial lifestyle recommendations. Given the possible role of hypertension in exacerbating her seizure disorder, the team decided to initiate an antihypertensive medication, opting for a calcium channel blocker due to its efficacy and tolerability in managing both blood pressure and potentially contributing to neurological stability. The decision was also influenced by the recognition of her postictal weakness, which was resolving but raised concerns about cerebral perfusion during hypertensive episodes.
As they awaited the effects of these interventions, the clinical team remained vigilant for signs of further seizure activity or additional complications. They planned to closely monitor her neurological status, blood pressure trends, and response to the increased lamotrigine dose. The integration of these findings emphasized the interconnected nature of her neurological and cardiovascular issues, highlighting the importance of a holistic approach in her ongoing care. The team was prepared to adjust their strategy as needed, with a focus on stabilizing the patient's condition and preventing progression to more severe seizure activity.
Section 3
As the clinical team monitored the patient, they observed a notable change in her status within 48 hours of initiating the antihypertensive therapy. Her blood pressure readings began to stabilize, averaging around 140/90 mmHg, which was a significant improvement. However, during this period, the patient experienced a new onset of mild headaches and transient episodes of blurred vision, which were not present before the adjustment in her treatment plan. Concerned about these new symptoms, the team conducted a thorough neurological reassessment and ordered a repeat set of laboratory tests, including serum electrolytes and renal function tests, to rule out any adverse effects from the new medication.
The laboratory results revealed a slight elevation in serum calcium levels, though still within the upper range of normal, which prompted the team to consider the possibility of hypercalcemia secondary to the calcium channel blocker. Additionally, the patient's neurological examination showed no new focal deficits, and her postictal weakness had completely resolved. Despite this, the intermittent headaches and blurred vision remained a concern, suggesting the potential for an underlying vascular component or a subtle side effect of medication.
In light of these developments, the clinical team decided to consult with a neurologist to explore the implications of the cortical lesion further and to ensure the headaches were not indicative of increased intracranial pressure or another evolving neurological issue. They also considered adjusting the dosage of the calcium channel blocker if the symptoms persisted, to balance the control of her hypertension with her overall neurological well-being. This multi-faceted approach aimed to address the interconnected challenges of her condition, emphasizing the need for ongoing assessment and flexibility in her management plan.
Section 4
As the neurologist reviewed the patient's case, they noted the stabilization of her blood pressure as a positive development but remained concerned about the persistent headaches and blurred vision. Given these symptoms, the neurologist ordered an MRI of the brain to rule out any acute changes, such as increased intracranial pressure or progression of the cortical lesion. Simultaneously, the team decided to closely monitor the patient's neurological status and vital signs, with a specific focus on any fluctuations in her blood pressure or signs of neurological distress.
The MRI results revealed no acute intracranial pathology, such as hemorrhage or significant edema, but did show subtle white matter changes suggestive of small vessel disease, which could be contributing to her symptoms. Additionally, the repeat laboratory tests showed a further increase in serum calcium to 10.8 mg/dL, still within normal limits but trending upwards, raising suspicion of mild hypercalcemia secondary to the calcium channel blocker. Her renal function remained stable, with a creatinine level of 1.0 mg/dL.
In response to these findings, the clinical team decided to adjust the patient's antihypertensive regimen, opting to reduce the dosage of the calcium channel blocker and introduce a low-dose diuretic to manage both her blood pressure and the potential hypercalcemia. This change aimed to alleviate her headaches and blurred vision while maintaining effective blood pressure control. The team also emphasized the need for ongoing monitoring of her electrolyte levels and neurological status, preparing for the possibility of further intervention if her symptoms persisted or new complications arose. This proactive approach underscored the importance of balancing her cardiovascular and neurological health, recognizing the interplay between her treatment and emerging symptoms.
Section 5
As the clinical team continued to monitor the patient following the adjustment of her antihypertensive regimen, they noted a significant change in her status. Within 48 hours, the patient reported a decrease in the intensity of her headaches and an improvement in her vision clarity, suggesting a positive initial response to the medication adjustment. However, during a routine neurological assessment, the nurse observed that the patient exhibited mild confusion and disorientation, particularly in the evenings. Her blood pressure, while mostly stable, occasionally spiked to 150/95 mmHg, particularly during periods of confusion. These episodes were accompanied by a mild tremor in her right hand and slight difficulty in coordinating her movements, raising concerns about potential underlying neurological complications.
In light of these new symptoms, the team ordered additional diagnostic tests, including an EEG to assess for any seizure activity that might be contributing to her cognitive changes. The EEG results showed intermittent focal slowing in the left temporal region, suggesting an increased risk of seizure activity, which aligned with her recent symptoms. Furthermore, a follow-up assessment of her serum calcium revealed a level of 11.2 mg/dL, indicating a progression toward hypercalcemia. This finding, combined with her neurological symptoms, prompted the team to consider the possibility of hypercalcemia-induced neurological disturbances.
Recognizing the need to address these evolving complications, the team decided to further adjust her treatment plan. They increased the dosage of the diuretic to enhance calcium excretion and introduced a low-dose anticonvulsant to manage the potential seizure risk. The team also planned for more frequent monitoring of her neurological status, electrolyte levels, and renal function. This comprehensive approach aimed not only to stabilize her current symptoms but also to prevent further complications, highlighting the intricate balance required in managing her complex health needs.